Literature DB >> 32522648

Are There Any Risk Factors Associated with the Presence of Cauda Equina Syndrome in Symptomatic Lumbar Disk Herniation?

Radek Kaiser1, Aneta Krajcová2, Petr Waldauf3, Nisaharan Srikandarajah4, Michal Makel5, Vladimír Beneš6.   

Abstract

OBJECTIVE: Risk factors for developing cauda equina syndrome (CES) caused by lumbar disk herniation (LDH) remain controversial and have not been established yet. The aim of the study was to investigate whether there is a relationship among age, sex, body mass index (BMI), or the degree of spinal canal compromise and the presence of CES in patients undergoing lumbar microdiskectomy.
METHODS: Between 2015 and 2019, 506 patients who had an operation for LDH compressing the dural sac were prospectively identified. The "prolapse-to-canal ratio" (PCR) was calculated as a proportion of the cross-sectional area of the disk prolapse compared with the total cross-sectional area of the spinal canal.
RESULTS: In total, 35 CES (6.9%) patients were identified. Multivariate logistic regression, adjusted for age, gender, BMI, and PCR, shows that only PCR was associated with the presence of CES (P < 0.001, area under the curve 0.7431). BMI was not associated with an increased risk of CES.
CONCLUSIONS: This study demonstrates a significant correlation between the size of LDH relative to size of the spinal canal and the presence of CES. A finding of LDH causing >60% obstruction of the spinal canal should be considered a red flag, and such patients need to be watched more closely.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cauda equina syndrome; Cross-sectional area; Diskectomy; Lumbar disk herniation; Obesity

Mesh:

Year:  2020        PMID: 32522648     DOI: 10.1016/j.wneu.2020.05.260

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  1 in total

1.  Body mass index has an impact on preoperative symptoms but not clinical outcome in acute cauda equina syndrome.

Authors:  Vicki M Butenschoen; Shadi Abulhala; Bernhard Meyer; Jens Gempt
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.